Travere Therapeutics Inc (TVTX) — Top EPS Revision Performer
As of 2026-05-05, Travere Therapeutics Inc (TVTX) has a next-year EPS growth estimate of 660.36%. Featured in 2 EPS revision reports, most recently on 2026-04-15. Sector: Healthcare.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 660.36%
- EPS growth this year
- 211.14%
- EPS next quarter (est)
- $-0.06
- Last price
- $44.80
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-05-05 | 660.36% | 211.14% | $-0.06 | $44.80 |
| 2026-05-04 | 686.24% | 200.71% | $-0.24 | $44.91 |
| 2026-05-03 | 686.24% | 200.71% | $-0.24 | $44.12 |
| 2026-04-30 | 686.24% | 200.71% | $-0.24 | $42.12 |
| 2026-04-29 | 690.56% | 196.20% | $-0.24 | $40.10 |
| 2026-04-28 | 690.56% | 196.20% | $-0.24 | $40.89 |
| 2026-04-27 | 690.56% | 196.20% | $-0.24 | $40.81 |
| 2026-04-26 | 634.79% | 200.98% | $-0.23 | $40.50 |
| 2026-04-24 | 634.79% | 200.98% | $-0.23 | $40.50 |
| 2026-04-23 | 630.85% | 200.98% | $-0.23 | $40.82 |
| 2026-04-22 | 630.85% | 200.98% | $-0.23 | $40.09 |
| 2026-04-21 | 630.85% | 200.98% | $-0.23 | $38.78 |
| 2026-04-20 | 633.84% | 199.92% | $-0.23 | $40.29 |
| 2026-04-19 | 633.84% | 199.92% | $-0.23 | $40.77 |
| 2026-04-16 | 633.31% | 199.92% | $-0.23 | $39.54 |
| 2026-04-15 | 633.31% | 199.92% | $-0.23 | $40.95 |
| 2026-04-14 | 622.52% | 201.46% | $-0.23 | $42.13 |
| 2026-04-13 | 545.76% | 213.57% | $-0.23 | $30.70 |
| 2026-04-12 | 548.79% | 213.04% | $-0.23 | $28.96 |
| 2026-04-10 | 548.79% | 213.04% | $-0.23 | $29.67 |
| 2026-04-09 | 548.79% | 213.04% | $-0.23 | $31.44 |
| 2026-04-08 | 548.79% | N/A | $-0.23 | $31.68 |
| 2026-04-07 | 519.71% | N/A | $-0.23 | $31.67 |
| 2026-04-06 | 519.71% | N/A | $-0.23 | $31.67 |
| 2026-04-05 | 545.73% | N/A | $-0.23 | $30.44 |
| 2026-04-03 | 519.71% | N/A | $-0.23 | $31.67 |
| 2026-04-02 | 519.71% | N/A | $-0.23 | $31.67 |
| 2026-04-01 | 519.71% | N/A | $-0.23 | $31.67 |
| 2026-04-01 | 545.73% | N/A | N/A | $29.71 |
| 2026-04-01 | 545.73% | N/A | N/A | $31.42 |
Reports Featuring TVTX
Recent News
- Four Biotech Stocks Near Buy Points As Earnings Season Kicks InInvestor's Business Daily
EPS revision data sourced from analyst consensus estimates, refreshed daily. Travere Therapeutics Inc (TVTX) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports